Submitted by Anonymous (not verified) on 5 March 2026 - 14:48
Human medicines European public assessment report (EPAR): Apidra, insulin glulisine, Date of authorisation: 27/09/2004, Revision: 35, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Apidra, insulin glulisine, Date of authorisation: 27/09/2004, Revision: 35, Status: Authorised